A paper, made visible
Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy.
Abstract evidence6 comparisonsAutomated source matching · not expert reviewed
Partial coverage · gaps are marked inside each comparison
- Some results can be visualized; unassessed context remains visible.
Choose a comparison
6 comparisons · Each follows its own evidence.
What happened? What does this reported comparison show?
One comparison, followed all the way through
This comparison is not yet interpretable.
Its exact outcome or compared groups still need to be established from the source.
1
Follow the study
The study design is not ready to draw
- Comparison-level assignment evidence has not been extracted.
2
Relative comparison
odds ratio
← Smaller odds ratioLarger odds ratio →
Reported statistic · comparison details unresolved0.92×
No difference
Reported estimateEqual steps show equal ratios
The reported number can be shown, but its exact outcome or compared groups are unresolved. Its direction cannot be interpreted here.
This picture is incomplete
- The outcome name has not been resolved from the source.
- The comparison labels have not both been resolved from the source.
- The outcome and group labels are not all tied to this result quotation.
- An uncertainty interval is unavailable.
4
Read the source context
Comparison details unresolved.
The exact outcome or compared groups are not yet fully established. The source needs interpretation before this number can support a conclusion.
Read reported excerpt
After adjusting for on-treatment serum low-density lipoprotein cholesterol and C-reactive protein concentrations, the odds of TVR with high-dose statin therapy remained significant (odds ratio: 0.74, p=0.015) while the odds of non-TVR did not (odds ratio: 0.92, p=0.55).
Automated source matching has not been reviewed by a scientific expert. This comparison's assignment method is not established.
5
Keep the limits in view
Study-specific limitations have not been assessed
- An empty limitations list does not mean the study has no limitations.
Inspect the source trail for this comparison
- Paper abstract ↗ · Abstractabstract · Matched to source text; not expert scientific review
After adjusting for on-treatment serum low-density lipoprotein cholesterol and C-reactive protein concentrations, the odds of TVR with high-dose statin therapy remained significant (odds ratio: 0.74, p=0.015) while the odds of non-TVR did not (odds ratio: 0.92, p=0.55).